Merger • Life Science

Spectrum Pharmaceuticals Acquires Allos Therapeutics

On September 6, 2012, Spectrum Pharmaceuticals acquired life science company Allos Therapeutics

Acquisition Context

This is Spectrum Pharmaceuticals’ 1st transaction in the Life Science sector.
This is Spectrum Pharmaceuticals’ 1st transaction in the United States.
This is Spectrum Pharmaceuticals’ 1st transaction in Colorado.

Explore All 192 Merger Life Science Deals - Search the Database Free

M&A Deal Summary
Date	September 6, 2012
Target	Allos Therapeutics
Sector	Life Science
Buyer(s)	Spectrum Pharmaceuticals
Deal Type	Merger

Target Company

Allos Therapeutics

Westminster, Colorado, United States

Allos Therapeutics, Inc. is a pharmaceutical company focused on developing and commercializing small molecule drugs for the treatment of cancer. The Company’s lead drug, Folotyn, was approved in September 2009 as the first FDA-approved drug for the treatment of relapsed or refractory peripheral T-cell lymphoma, a rare cancer whose sufferers have a very poor prognosis.

Explore More Deals

Browse All 215,262 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Spectrum Pharmaceuticals

Boston, Massachusetts, United States

Category	Company
Founded	1987
Sector	Life Science
Revenue	26M USD (2023)

DESCRIPTION

Spectrum Pharmaceuticals is a biotechnology company focused on acquiring, developing and commercializing drug products with a primary focus in oncology and hematology. Spectrum Pharmaceuticals was founded in 1987 and is based in Boston, Massachusetts.

Deal Context for Buyer	#
Overall	1 of 2
Sector: Life Science	1 of 2
Type: Merger	1 of 1
State: Colorado	1 of 1
Country: United States	1 of 2
Year: 2012	1 of 1

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2013-07-17	Talon Therapeutics San Francisco, California, United States Talon Therapeutics (fka Hana Biosciences) is a biopharmaceutical company dedicated to seizing upon medical opportunities, efficiently and expertly leading product candidates through clinical development, and transferring value to patients, patient care providers, shareholders, corporate partners, and employees.	Buy	-

DATE

TARGET

DEAL TYPE

VALUE

2013-07-17

Talon Therapeutics

San Francisco, California, United States

Talon Therapeutics (fka Hana Biosciences) is a biopharmaceutical company dedicated to seizing upon medical opportunities, efficiently and expertly leading product candidates through clinical development, and transferring value to patients, patient care providers, shareholders, corporate partners, and employees.

Buy

Explore Related M&A Activity

Life Science M&A - Merger M&A Deals - Colorado M&A - United States M&A - 2012 M&A